Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure-Reference-Cited by-同舟云学术

Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure

Published:2002-04 Issue:7 Volume:39 Page:1175-1181
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Hambrecht Rainer,Schulze Paul Christian,Gielen Stephan,Linke Axel,Möbius-Winkler Sven,Yu Jiangtao,Kratzsch J.ürgen,Baldauf Gerhard,Busse Martin W,Schubert Andreas,Adams Volker,Schuler Gerhard

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Wasting as independent risk factor for mortality in chronic heart failure;Anker;Lancet,1997

2. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure;Anker;Eur Heart J,1999

3. Tumor necrosis factor and steroid metabolism in chronic heart failure;Anker;J Am Coll Cardiol,1997

4. Increased resting metabolic rate in patients with congestive heart failure;Poehlman;Ann Intern Med,1994

5. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia;Anker;Circulation,1997

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF;Frontiers in Cardiovascular Medicine;2023-10-27

2. Skeletal muscle atrophy, regeneration, and dysfunction in heart failure: Impact of exercise training;Journal of Sport and Health Science;2023-09

3. Prognostic Value of Insulin Resistance Assessed by HOMA-IR in Non-Diabetic Patients with Decompensated Heart Failure;Current Problems in Cardiology;2023-06

4. Sarcopenia and cardiovascular diseases: A systematic review and meta‐analysis;Journal of Cachexia, Sarcopenia and Muscle;2023-04

5. A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy;Therapeutic Advances in Cardiovascular Disease;2023-01